Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Treatment of fractures of the tibial plateau (Schatzker VI) with external fixators versus plate osteosynthesis.

Bove F, Sala F, Capitani P, Thabet AM, Scita V, Spagnolo R.

Injury. 2018 Nov;49 Suppl 3:S12-S18. doi: 10.1016/j.injury.2018.09.059.

PMID:
30415663
2.

Movement disorders phenomenology in focal motor seizures.

Fasano A, Di Bonaventura C, Bove F, Espay AJ, Morgante F, Fabbrini G, Munhoz RP, Andrade D, Borlot F, Bui E, Di Gennaro G, Iorio R, Katzberg H, Luigetti M, Striano P, Defazio G, Berardelli A.

Parkinsonism Relat Disord. 2019 Apr;61:161-165. doi: 10.1016/j.parkreldis.2018.10.021. Epub 2018 Oct 16.

PMID:
30361137
3.

Survey of Satisfaction of Biological Treatments in a Regional Hospital.

Grados D, Cucurell M, Bové F, Retamero A.

Reumatol Clin. 2018 Oct 15. pii: S1699-258X(18)30186-4. doi: 10.1016/j.reuma.2018.08.006. [Epub ahead of print] English, Spanish. No abstract available.

4.

A role for accelerometry in the differential diagnosis of tremor syndromes.

Bove F, Di Lazzaro G, Mulas D, Cocciolillo F, Di Giuda D, Bentivoglio AR.

Funct Neurol. 2018 Jan/Mar;33(1):45-49.

5.

Canopy physiology, vine performance and host-pathogen interaction in a fungi resistant cv. Sangiovese x Bianca accession vs. a susceptible clone.

Poni S, Chiari G, Caffi T, Bove F, Tombesi S, Moncalvo A, Gatti M.

Sci Rep. 2017 Jul 20;7(1):6092. doi: 10.1038/s41598-017-05530-7.

6.

Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel.

Bove F, Bentivoglio AR, Naranian T, Fasano A.

Parkinsonism Relat Disord. 2017 Sep;42:109-111. doi: 10.1016/j.parkreldis.2017.06.015. Epub 2017 Jun 27. No abstract available.

PMID:
28676196
7.

Levodopa-Carbidopa Intestinal Gel in a Pediatric Parkinsonism-plus Syndrome.

Vita MG, Bove F, Mariotti P, Riccioni ME, Leuzzi V, Bentivoglio AR.

Mov Disord Clin Pract. 2017 Jun 29;4(5):791-792. doi: 10.1002/mdc3.12509. eCollection 2017 Sep-Oct. No abstract available.

8.

Open Supracondylar-Intercondylar Fractures of the Femur Treatment With Taylor Spatial Frame.

Sala F, Thabet AM, Capitani P, Bove F, Abdelgawad AA, Lovisetti G.

J Orthop Trauma. 2017 Oct;31(10):546-553. doi: 10.1097/BOT.0000000000000923.

PMID:
28650942
9.

Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.

Bove F, Luigetti M, Gallicchio L, Recchia V, Petruzzellis A, Di Iorio R, Tamma F, Fasano A.

Neurol Sci. 2017 Oct;38(10):1869-1872. doi: 10.1007/s10072-017-3029-z. Epub 2017 Jun 22.

PMID:
28642996
10.

New olfactometric findings in Parkinson's disease.

Passali GC, Bove F, Vargiu L, Bentivoglio AR, Anzivino R, De Corso E, Galli J, Rigante M, Pandolfini M, Sergi B, Giuliani M, Cianfrone F, Paludetti G, Fasano A.

Clin Otolaryngol. 2017 Aug;42(4):837-843. doi: 10.1111/coa.12816. Epub 2017 Feb 1.

PMID:
28004533
11.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

12.

24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.

Ricciardi L, Bove F, Espay KJ, Lena F, Modugno N, Poon YY, Krikorian R, Espay AJ, Fasano A.

Mov Disord. 2016 Apr;31(4):597-8. doi: 10.1002/mds.26564. Epub 2016 Mar 4. No abstract available.

PMID:
26946221
13.

Reconstructing Historical VOC Concentrations in Drinking Water for Epidemiological Studies at a U.S. Military Base: Summary of Results.

Maslia ML, Aral MM, Ruckart PZ, Bove FJ.

Water (Basel). 2016;8(10):449. doi: 10.3390/w8100449. Epub 2016 Oct 13.

14.

Evaluation of contaminated drinking water and male breast cancer at Marine Corps Base Camp Lejeune, North Carolina: a case control study.

Ruckart PZ, Bove FJ, Shanley E 3rd, Maslia M.

Environ Health. 2015 Sep 16;14:74. doi: 10.1186/s12940-015-0061-4.

15.

Iron chelation therapy to prevent the manifestations of aceruloplasminemia.

Bove F, Fasano A.

Neurology. 2015 Sep 22;85(12):1085-6. doi: 10.1212/WNL.0000000000001956. Epub 2015 Aug 26. No abstract available.

PMID:
26311749
17.

Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study.

Bove FJ, Ruckart PZ, Maslia M, Larson TC.

Environ Health. 2014 Aug 13;13:68. doi: 10.1186/1476-069X-13-68.

18.

Tactile and proprioceptive temporal discrimination are impaired in functional tremor.

Tinazzi M, Fasano A, Peretti A, Bove F, Conte A, Dallocchio C, Arbasino C, Defazio G, Fiorio M, Berardelli A.

PLoS One. 2014 Jul 22;9(7):e102328. doi: 10.1371/journal.pone.0102328. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e111287. Dall'Occhio, Carlo [corrected to Dallocchio, Carlo].

19.

Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth.

Fasano A, Bove F, Gabrielli M, Ragazzoni E, Fortuna S, Tortora A, Zocco MA, Marconi S, Gasbarrini A, Bentivoglio AR.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):91-5. doi: 10.1097/WNF.0000000000000034.

PMID:
24992085
20.

Treatment outcome of patients with comorbid type 1 diabetes and eating disorders.

Custal N, Arcelus J, Agüera Z, Bove FI, Wales J, Granero R, Jiménez-Murcia S, Sánchez I, Riesco N, Alonso P, Crespo JM, Virgili N, Menchón JM, Fernandez-Aranda F.

BMC Psychiatry. 2014 May 16;14:140. doi: 10.1186/1471-244X-14-140.

21.

PCR detection of Neospora caninum in water buffalo foetal tissues.

Auriemma C, Lucibelli MG, Borriello G, De Carlo E, Martucciello A, Schiavo L, Gallo A, Bove F, Corrado F, Girardi S, Amoroso MG, Ďegli Uberti B, Galiero G.

Acta Parasitol. 2014 Mar;59(1):1-4. doi: 10.2478/s11686-014-0201-y. Epub 2014 Feb 26.

PMID:
24570043
22.

Evaluation of mortality among marines and navy personnel exposed to contaminated drinking water at USMC base Camp Lejeune: a retrospective cohort study.

Bove FJ, Ruckart PZ, Maslia M, Larson TC.

Environ Health. 2014 Feb 19;13(1):10. doi: 10.1186/1476-069X-13-10.

24.

The treatment of dystonic tremor: a systematic review.

Fasano A, Bove F, Lang AE.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):759-69. doi: 10.1136/jnnp-2013-305532. Epub 2013 Oct 28. Review.

PMID:
24167042
25.

The role of small intestinal bacterial overgrowth in Parkinson's disease.

Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, Fortuna S, Tortora A, Di Giacopo R, Campanale M, Gigante G, Lauritano EC, Navarra P, Marconi S, Gasbarrini A, Bentivoglio AR.

Mov Disord. 2013 Aug;28(9):1241-9. doi: 10.1002/mds.25522. Epub 2013 May 27.

PMID:
23712625
26.

Xeomin(®) use in patients with systemic immune reactions to other botulinum toxins type A.

Ricciardi L, Bove F, Fasano A.

Eur J Neurol. 2013 Mar;20(3):e45-6. doi: 10.1111/ene.12076. No abstract available.

PMID:
23406455
27.

Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia.

Tinazzi M, Marotta A, Fasano A, Bove F, Bentivoglio AR, Squintani G, Pozzer L, Fiorio M.

Brain. 2013 Mar;136(Pt 3):782-9. doi: 10.1093/brain/aws372. Epub 2013 Feb 11.

PMID:
23404333
28.

Temporal discrimination in patients with dystonia and tremor and patients with essential tremor.

Tinazzi M, Fasano A, Di Matteo A, Conte A, Bove F, Bovi T, Peretti A, Defazio G, Fiorio M, Berardelli A.

Neurology. 2013 Jan 1;80(1):76-84. doi: 10.1212/WNL.0b013e31827b1a54. Epub 2012 Dec 12.

PMID:
23243072
29.

Cognitive-behavioral therapy for pathological gambling in Parkinson's disease: a pilot controlled study.

Jiménez-Murcia S, Bove FI, Israel M, Steiger H, Fernández-Aranda F, Alvarez-Moya E, Granero R, Penelo E, Vergé B, Aymamí MN, Santamaría JJ, Gómez-Peña M, Moragas L, Savvidou LG, Menchón JM.

Eur Addict Res. 2012;18(6):265-74. doi: 10.1159/000337442. Epub 2012 Jul 3.

30.

The neurobiology of falls.

Fasano A, Plotnik M, Bove F, Berardelli A.

Neurol Sci. 2012 Dec;33(6):1215-23. doi: 10.1007/s10072-012-1126-6. Epub 2012 Jun 5. Review.

PMID:
22673818
31.

Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.

Di Giacopo R, Fasano A, Quaranta D, Della Marca G, Bove F, Bentivoglio AR.

Mov Disord. 2012 Apr;27(4):559-61. doi: 10.1002/mds.24909. Epub 2012 Jan 30.

PMID:
22290743
32.

Association between cumulative fiber exposure and respiratory outcomes among Libby vermiculite workers.

Larson TC, Antao VC, Bove FJ, Cusack C.

J Occup Environ Med. 2012 Jan;54(1):56-63. doi: 10.1097/JOM.0b013e31823c141c.

PMID:
22227874
33.

Complexities in hindcasting models--when should we say enough is enough.

Maslia ML, Aral MM, Faye RE, Grayman WM, Suárez-Soto RJ, Sautner JB, Anderson BA, Bove FJ, Ruckart PZ, Moore SM.

Ground Water. 2012 Jan-Feb;50(1):10-6; discussion 16-8. doi: 10.1111/j.1745-6584.2011.00884.x. Epub 2011 Dec 7. No abstract available.

PMID:
22150251
34.

Using survey results regarding hepatitis B knowledge, community awareness and testing behavior among Asians to improve the San Francisco Hep B Free campaign.

Shiau R, Bove F, Henne J, Zola J, Fang T, Fernyak S.

J Community Health. 2012 Apr;37(2):350-64. doi: 10.1007/s10900-011-9452-9.

PMID:
21874365
35.

Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story.

Bentivoglio AR, Ialongo T, Bove F, De Nigris F, Fasano A.

Neurol Sci. 2012 Apr;33(2):261-7. doi: 10.1007/s10072-011-0672-7. Epub 2011 Jun 28.

PMID:
21710123
36.

Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients.

Tendas A, Niscola P, Cupelli L, Spagnoli A, Scaramucci L, Giovannini M, Ales M, Cudillo L, Picardi A, Mirabile M, Bove F, Falco S, Dentamaro T, Fabritiis Pd.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):408-10. doi: 10.1086/659257. No abstract available.

PMID:
21460500
37.

Effect of executive functioning, decision-making and self-reported impulsivity on the treatment outcome of pathologic gambling.

Alvarez-Moya EM, Ochoa C, Jiménez-Murcia S, Aymamí MN, Gómez-Peña M, Fernández-Aranda F, Santamaría J, Moragas L, Bove F, Menchón JM.

J Psychiatry Neurosci. 2011 May;36(3):165-75. doi: 10.1503/jpn.090095.

38.

Treatment of femoral diaphyseal non-unions: our experience.

Benazzo F, Mosconi M, Bove F, Quattrini F.

Injury. 2010 Nov;41(11):1156-60. doi: 10.1016/j.injury.2010.08.010. Epub 2010 Oct 13.

PMID:
20947078
39.

Vermiculite worker mortality: estimated effects of occupational exposure to Libby amphibole.

Larson TC, Antao VC, Bove FJ.

J Occup Environ Med. 2010 May;52(5):555-60. doi: 10.1097/JOM.0b013e3181dc6d45.

PMID:
20431408
40.

Age of onset in pathological gambling: clinical, therapeutic and personality correlates.

Jiménez-Murcia S, Alvarez-Moya EM, Stinchfield R, Fernández-Aranda F, Granero R, Aymamí N, Gómez-Peña M, Jaurrieta N, Bove F, Menchón JM.

J Gambl Stud. 2010 Jun;26(2):235-48. doi: 10.1007/s10899-009-9175-3.

PMID:
20063194
41.

Comorbidity in pathological gambling: clinical variables, personality and treatment response.

Jiménez-Murcia S, Granero Pérez R, Fernández-Aranda F, Alvarez Moya E, Aymamí MN, Gómez-Peña M, Bueno B, Santamaría JJ, Moragas L, Penelo E, Jaurrieta N, Alonso MP, Segalàs C, Real E, Labad J, Bove F, Vallejo J, Menchón JM.

Rev Psiquiatr Salud Ment. 2009 Oct;2(4):178-89. doi: 10.1016/S1888-9891(09)73236-7. Epub 2010 Jan 25. English, Spanish.

PMID:
23034347
42.
43.

Analysis of 80 bilateral hip replacement surgeries performed in a single session. Feasibility study.

Bove F, Costantino E, Volpato F, Russo R.

Chir Organi Mov. 2005 Oct-Dec;90(4):339-43. English, Italian.

PMID:
16878768
44.

Lead exposure and birth outcomes in five communities in Shoshone County, Idaho.

Berkowitz Z, Price-Green P, Bove FJ, Kaye WE.

Int J Hyg Environ Health. 2006 Mar;209(2):123-32. Epub 2005 Dec 22.

PMID:
16376613
45.

Wilms' tumor and exposures to residential and occupational hazardous chemicals.

Tsai J, Kaye WE, Bove FJ.

Int J Hyg Environ Health. 2006 Jan;209(1):57-64. Epub 2005 Oct 12.

PMID:
16373202
46.

Long-term neurobehavioral health effects of methyl parathion exposure in children in Mississippi and Ohio.

Ruckart PZ, Kakolewski K, Bove FJ, Kaye WE.

Environ Health Perspect. 2004 Jan;112(1):46-51.

47.

[Cancer risk in breast lesions: diagnostic and therapeutic strategy].

Bove F, Bilancio G, De Falco M, Parmeggiani D, Sperlongano P, Barbarisi A, Parmeggiani U.

Minerva Chir. 2003 Jun;58(3):375-83. Italian.

PMID:
12955059
48.

Population exposures to I-131 releases from Hanford Nuclear Reservation and preterm birth, infant mortality, and fetal deaths.

Tatham LM, Bove FJ, Kaye WE, Spengler RF.

Int J Hyg Environ Health. 2002 Mar;205(1-2):41-8.

PMID:
12018015
49.

Elevated birth defects in racial or ethnic minority children of women living near hazardous waste sites.

Orr M, Bove F, Kaye W, Stone M.

Int J Hyg Environ Health. 2002 Mar;205(1-2):19-27.

PMID:
12018013
50.

Drinking water contaminants and adverse pregnancy outcomes: a review.

Bove F, Shim Y, Zeitz P.

Environ Health Perspect. 2002 Feb;110 Suppl 1:61-74. Review.

Supplemental Content

Support Center